Skip to content

Clinical trials

Lupus Erythematosus, Systemic trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lupus Erythematosus, Systemic Country / region: Australia Clear all

58 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20051
20072
20081
20101
20113
20122
20131
20151
20173
20183
20193
20205
20212
20223
20235
20244
20258
20269

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed23
Recruiting18
Terminated7
Active, not recruiting7
Not yet recruiting1
Enrolling by invitation1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Novartis Pharmaceuticals6
AstraZeneca4
Bristol-Myers Squibb4
Eli Lilly and Company4
AbbVie3
Amgen3
EMD Serono Research & Development Institute, Inc.3
Janssen Research & Development, LLC2
UCB Pharma2
Baxalta now part of Shire1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lupus Erythematosus, Systemic58
Lupus Nephritis10
Arthritis, Rheumatoid9
Autoimmune Diseases8
Lupus Erythematosus, Cutaneous5
Connective Tissue Diseases4
Lupus Erythematosus, Discoid4
Scleroderma, Systemic4
Immune System Diseases3
Myositis3

Trials

Showing 76 to 58 of 58. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.